900656
Methoxy poly(ethylene glycol)-b-poly(L-lactide)
5k-10k
Synonym(s):
mPEG-b-PLA, mPEG-PLA, mPEG-PLLA
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
HO[CH(CH3)COO]m[CH2CH2O]nCH3
NACRES:
NA.23
UNSPSC Code:
12162002
Application
Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly(L-lactide) (PLLA) block. These materials have been used in control release and nanoparticle formulation for drug encapsulation and delivery applications. Well-defined materials with varying properties can be prepared by controlling the relative length of each polymer block. Hydroxyl termination allows for facile further chemical modification of these materials.
Still not finding the right product?
Explore all of our products under Methoxy poly(ethylene glycol)-b-poly(L-lactide)
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
>230.7 °F
flash_point_c
> 110.4 °C
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
The development of drugs that target specific locations within the human body remains one of the greatest challenges in biomedicine today.
Injectable biodegradable polymeric system for preserving the active form and delayed-release of camptothecin anticancer drugs.
Mert O, et al.
Royal Society of Chemistry Advances, 2(1), 176-185 (2012)
Zhigang Xie et al.
Journal of biomedical materials research. Part A, 88(1), 238-245 (2008-02-21)
Docetaxel (DX) is one of the most effective antineoplastic drugs. Its current clinical administration is limited because of its hydrophobicity and serious side effects. A polymer/DX conjugate is designed and successfully prepared to solve these problems. It is monomethoxy-poly(ethylene glycol)-block-poly(L-lactide)/DX
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 900656-500MG | 04061833250693 |